Discounting future health

In Emanuel Norheim (ed.), Global health priority-setting: Cost-effectiveness and beyond. Oxford, England: Oxford University Press (forthcoming)
Download Edit this record How to cite View on PhilPapers
In carrying out cost-benefit or cost-effective analysis, a discount rate should be applied to some kinds of future benefits and costs. It is controversial, though, whether future health is in this class. I argue that one of the standard arguments for discounting (from diminishing marginal returns) is inapplicable to the case of health, while another (favouring a pure rate of time preference) is unsound in any case. However, there are two other reasons that might support a positive discount rate for future health: one relating to uncertainty, and the other relating to the instrumental benefits of improved health. While the latter considerations could be modelled via a discount rate, they could alternatively be modelled more explicitly, in other ways; I briefly discuss which modelling method is preferable. Finally, I argue against the common claims that failing to discount future health would lead to paradox, and/or to inconsistency with the way future cash flows are treated.
No keywords specified (fix it)
PhilPapers/Archive ID
Upload history
Archival date: 2017-07-08
View other versions
Added to PP index

Total views
273 ( #25,111 of 65,560 )

Recent downloads (6 months)
40 ( #21,186 of 65,560 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.